🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,027 results for “ERA” Clear

  1. SAB-185

    SAB Biotherapeutics

    COVID-19

    phase 1 mab active

    2 trials

  2. SAB-301

    SAB Biotherapeutics

    Middle East Respiratory Syndrome Coronavirus

    phase 1 mab completed

    1 trial

  3. SAR441000

    Atrium Therapeutics

    Metastatic Neoplasm

    phase 1 small molecule terminated

    1 trial

  4. SB-728-T

    SANGAMO THERAPEUTICS, INC

    HIV Infection

    phase 1 gene therapy completed

    1 trial

  5. SB-728mR-HSPC Infusion 3 days following busulfan conditioning

    SANGAMO THERAPEUTICS, INC

    HIV

    phase 1 gene therapy active

    1 trial

  6. SB-FIX

    SANGAMO THERAPEUTICS, INC

    Hemophilia B

    phase 1 mab terminated

    1 trial

  7. SC HYLENEX and Ceftriaxone

    HALOZYME THERAPEUTICS, INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  8. SER-214

    Serina Therapeutics

    Parkinson's Disease

    phase 1 small molecule active

    1 trial

  9. SER-252 (PEOZ-apomorphine)

    Serina Therapeutics

    PARKINSON DISEASE (Disorder)

    phase 1 small molecule active

    1 trial

  10. SER-262

    Seres Therapeutics

    Clostridium Difficile Infection

    phase 1 small molecule completed

    1 trial

  11. SER-287

    Seres Therapeutics

    Ulcerative Colitis

    phase 1 small molecule completed

    1 trial

  12. SHP465 12.5mg

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    phase 1 small molecule completed

    1 trial

  13. SION-451

    Sionna Therapeutics

    Cystic Fibrosis (CF)

    phase 1 small molecule active

    1 trial

  14. SKY0402

    Pacira Ireland Limited

    Postoperative Pain Management

    phase 1 small molecule completed

    1 trial

  15. SLN124

    Silence Therapeutics plc

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  16. SLN124

    Silence Therapeutics plc

    Non-transfusion-dependent Thalassemia

    phase 1 small molecule completed

    1 trial

  17. SLN124 is a GalNAc conjugated double stranded fully modified siRNA. Sodium chloride 0.9% w/v is used as Placebo

    Silence Therapeutics plc

    Non-transfusion-dependent Thalassemia

    phase 1 small molecule terminated

    1 trial

  18. SLN360

    Silence Therapeutics plc

    Hyperlipidemias

    phase 1 small molecule completed

    1 trial

  19. SMT C1100

    Summit Therapeutics

    Muscular Dystrophy, Duchenne

    phase 1 small molecule completed

    1 trial

  20. SMT C1100

    Summit Therapeutics

    Duchenne Muscular Dystrophy

    phase 1 small molecule completed

    1 trial

  21. SOC + TSC-100

    TScan Therapeutics

    AML

    phase 1 small molecule active

    1 trial

  22. SOM 230 / Pasireotide

    United Therapeutics Europe Ltd

    Atypical Ductal Breast Hyperplasia

    phase 1 small molecule completed

    1 trial

  23. SPARC1210

    Advanced Accelerator Applications

    Breast Cancer

    phase 1 small molecule terminated

    1 trial

  24. SPARC1613

    Advanced Accelerator Applications

    Recurrent or Metastatic Breast Cancer

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources